WSM Stock Analysis: Williams-Sonoma | NYSE
Specialty Retail | NYSE, USA | Market Cap: 26.931m USD | 12M Return: 21.5% | US9699041011 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 260M
EPS Trend: -18.7%
Qual. Beats: 0
Rev. Trend: 50.4%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Williams-Sonoma, Inc. (NYSE: WSM) is a U.S.-based omni-channel specialty retailer offering a broad range of home-related products, including cookware, dining and entertaining items, furniture, bedding, lighting, rugs, decor, and personalized or made-to-order goods. It sells primarily under a portfolio of nine distinct brands-Williams Sonoma, Pottery Barn, Pottery Barn Kids, Pottery Barn Teen, West Elm, Williams Sonoma Home, Rejuvenation, Mark and Graham, and GreenRow-each targeting different customer segments and aesthetic preferences. Products reach consumers through e-commerce websites, direct-mail catalogs, and physical retail stores in the U.S. and internationally. The company was founded in 1956 and is headquartered in San Francisco, California.
As a large-cap consumer discretionary stock in the homefurnishing retail sub-industry, Williams-Sonomas performance is closely tied to housing turnover, real estate values, and broader consumer spending on the home. Its multi-brand, multi-channel model-combining owned e-commerce, catalog marketing, and branded retail stores-is a distinctive feature of its strategy, allowing it to capture customers across demographics and price points while maintaining direct relationships with end consumers rather than relying on third-party wholesale distribution.
- Housing market weakness pressures furniture demand across core brands
- Tariff and freight costs squeeze gross margins
- B2B segment drives double-digit growth offsetting retail softness
| Net Income: 1.18b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.24 > 0.02 and ΔFCF/TA 4.79 > 1.0 |
| NWC/Revenue: 10.59% < 20% (prev 11.36%; Δ -0.76% < -1%) |
| CFO/TA 0.29 > 3% & CFO 1.61b > Net Income 1.18b |
| Net Debt (499.0m) to EBITDA (1.77b): 0.28 < 3 |
| Current Ratio: 1.45 > 1.5 & < 3 |
| Outstanding Shares: last quarter (118.9m) vs 12m ago -3.81% < -2% |
| Gross Margin: 47.19% > 18% (prev 45.77%; Δ 1.42% > 0.5%) |
| Asset Turnover: 149.1% > 50% (prev 149.8%; Δ -0.61% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.15 (Total Current Assets 2.75b - Total Current Liabilities 1.90b) / Total Assets 5.51b |
| B: 0.29 (Retained Earnings 1.61b / Total Assets 5.51b) |
| C: 0.29 (EBIT TTM 1.54b / Avg Total Assets 5.37b) |
| D: 0.64 (Book Value of Equity 2.14b / Total Liabilities 3.37b) |
| Altman-Z'' = 4.56 = AA |
| DSRI: 1.24 (Receivables 146.2m/115.5m, Revenue 8.01b/7.83b) |
| GMI: 0.97 (GM 45.77% / 47.19%) |
| AQI: 0.93 (AQ_t 0.06 / AQ_t-1 0.06) |
| SGI: 1.02 (Revenue 8.01b / 7.83b) |
| TATA: -0.08 (NI 1.18b - CFO 1.61b) / TA 5.51b) |
| Beneish M = -2.89 (Cap -4..+1) = A |
As of September 30, 2026, the stock is trading at USD 229.96 with a total of 655,286 shares traded. Over the past week, the price has changed by -1.17%, over one month by +0.75%, over three months by -3.93% and over the past year by +21.47%.
Current recommended Stop Loss: 213.10 (which is 7.3% or 2.4 ATR below the current price).
Williams-Sonoma has received a consensus analysts rating of 3.46. Therefore, it is recommended to hold WSM.
- StrongBuy: 6
- Buy: 1
- Hold: 15
- Sell: 2
- StrongSell: 0
| Analysts Target Price | 247.9 | 7.8% |
P/E Trailing = 23.4523
P/E Forward = 24.57
P/S = 3.3639
P/B = 14.3993
P/EG = 3.0094
Revenue TTM = 8.01b USD
EBIT TTM = 1.54b USD
EBITDA TTM = 1.77b USD
Long Term Debt = 1.31b USD (estimated: total debt 1.53b - short term 217.0m)
Short Term Debt = 217.0m USD (from shortTermDebt, last quarter)
Debt = 1.53b USD (from shortLongTermDebtTotal, last quarter) (leases 1.53b already included)
Net Debt = 499.0m USD (calculated: Debt 1.53b - CCE 1.03b)
Enterprise Value = 27.4b USD (26.9b + Debt 1.53b - CCE 1.03b)
Interest Coverage Ratio = unknown (Ebit TTM 1.54b / Interest Expense TTM 0.0)
EV/FCF = 20.38x (Enterprise Value 27.4b / FCF TTM 1.35b)
FCF Yield = 4.91% (FCF TTM 1.35b / Enterprise Value 27.4b)
FCF Margin = 16.81% (FCF TTM 1.35b / Revenue TTM 8.01b)
Net Margin = 14.73% (Net Income TTM 1.18b / Revenue TTM 8.01b)
Gross Margin = 47.19% ((Revenue TTM 8.01b - Cost of Revenue TTM 4.23b) / Revenue TTM)
Gross Margin QoQ = 51.64% (prev 43.95%)
Tobins Q-Ratio = 4.98 (Enterprise Value 27.4b / Total Assets 5.51b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 1.53b)
Taxrate = 25.14% (395.9m / 1.57b)
NOPAT = 1.15b (EBIT 1.54b * (1 - 25.14%))
Current Ratio = 1.45 (Total Current Assets 2.75b / Total Current Liabilities 1.90b)
Debt / Equity = 0.71 (Debt 1.53b / totalStockholderEquity, last quarter 2.14b)
Debt / EBITDA = 0.28 (Net Debt 499.0m / EBITDA 1.77b)
Debt / FCF = 0.37 (Net Debt 499.0m / FCF TTM 1.35b)
Total Stockholder Equity = 2.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 21.97% (Net Income 1.18b / Total Assets 5.51b)
RoE = 57.79% (Net Income TTM 1.18b / Total Stockholder Equity 2.04b)
RoCE = 45.88% (EBIT 1.54b / Capital Employed (Equity 2.04b + L.T.Debt 1.31b))
RoIC = 33.61% (NOPAT 1.15b / Invested Capital 3.42b)
WACC = 9.39% (E(26.9b)/V(28.5b) * Re(9.92%) + D(1.53b)/V(28.5b) * Rd(0.0%) * (1-Tc(0.25)))
Discount Rate = 9.92% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.77 | Cagr: -4.10%
[DCF] Terminal Value 74.69% ; FCFF base≈1.22b ; Y1≈1.40b ; Y5≈2.06b
[DCF] Fair Price = 217.9 (EV 26.2b - Net Debt 499.0m = Equity 25.7b / Shares 117.8m; r=9.39% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -18.74 | EPS CAGR: -2.30% | SUE: 0.56 | # QB: 0
Revenue Correlation: 50.41 | Revenue CAGR: 1.04% | SUE: 0.67 | # QB: 0
EPS current Quarter (2026-10-31): EPS=2.20 | Chg30d=+3.21% | Revisions=+31% | Analysts=12
EPS current Year (2027-01-31): EPS=9.85 | Chg30d=+5.03% | Revisions=+69% | GrowthEPS=+11.4% | GrowthRev=+5.9%
EPS next Year (2028-01-31): EPS=10.51 | Chg30d=+2.56% | Revisions=+82% | GrowthEPS=+6.7% | GrowthRev=+5.3%
[Analyst] Revisions Ratio: +70% (up=35, down=5)